urb937 has been researched along with Nausea* in 1 studies
1 other study(ies) available for urb937 and Nausea
| Article | Year |
|---|---|
Suppression of acute and anticipatory nausea by peripherally restricted fatty acid amide hydrolase inhibitor in animal models: role of PPARα and CB
Effective treatments of nausea are limited. In this study we evaluated the ability of the peripherally restricted fatty acid amide hydrolase (FAAH) inhibitor, URB937, to suppress acute and anticipatory nausea in rats and examined the pharmacological mechanism of this effect.. We investigated the potential of URB937 (administered i.p.) to reduce the establishment of lithium chloride-induced conditioned gaping (model of acute nausea) and to reduce the expression of contextually-elicited conditioned gaping (model of anticipatory nausea) in rats. The role of CB. URB937 reduced acute nausea by a PPARα-dependent mechanism and reduced anticipatory nausea by a CB. The anti-nausea action of URB937 may occur in the AP and may involve PPARα to suppress acute nausea and CB Topics: Acute Disease; Amidohydrolases; Animals; Blood-Brain Barrier; Brain; Butyrates; Cannabinoids; Disease Models, Animal; Injections, Intraperitoneal; Male; Nausea; Phenylurea Compounds; PPAR alpha; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Vomiting, Anticipatory | 2017 |